Cargando…
Small Molecules Enhance Scaffold-Based Bone Grafts via Purinergic Receptor Signaling in Stem Cells
The need for bone grafts is high, due to age-related diseases, such as tumor resections, but also accidents, risky sports, and military conflicts. The gold standard for bone grafting is the use of autografts from the iliac crest, but the limited amount of accessible material demands new sources of b...
Autores principales: | Ottensmeyer, Patrick Frank, Witzler, Markus, Schulze, Margit, Tobiasch, Edda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274752/ https://www.ncbi.nlm.nih.gov/pubmed/30441872 http://dx.doi.org/10.3390/ijms19113601 |
Ejemplares similares
-
Non-Cytotoxic Agarose/Hydroxyapatite Composite Scaffolds for Drug Release
por: Witzler, Markus, et al.
Publicado: (2019) -
Polysaccharide-Based Systems for Targeted Stem Cell Differentiation and Bone Regeneration
por: Witzler, Markus, et al.
Publicado: (2019) -
The role of purinergic receptors in stem cell differentiation
por: Kaebisch, Constanze, et al.
Publicado: (2014) -
Stem Cells on Biomaterials for Synthetic Grafts to Promote Vascular Healing
por: Babczyk, Patrick, et al.
Publicado: (2014) -
Lignin-Derived Biomaterials for Drug Release and Tissue Engineering
por: Witzler, Markus, et al.
Publicado: (2018)